Bengaluru-based Narayana Health has made a landmark move into the international healthcare arena by acquiring the UK-based Practice Plus Group Hospitals (PPG) in a deal valued at approximately ₹2,200 crore (GBP 188.78 million).
The acquisition gives Narayana full control of Practice Plus Group, the fifth-largest private hospital network in the UK, which operates 12 hospitals and surgical centres, boasting around 330 in-patient and outpatient beds.
According to disclosure filings, PPG generates the bulk of its revenues—approximately 93 percent—from contracts with the UK’s publicly funded National Health Service (NHS), with a focus on orthopaedics, ophthalmology, and general surgery.
In announcing the deal, Narayana’s founder-chairman Dr. Devi Prasad Shetty said the acquisition aligns with the company’s mission to deliver accessible, high-quality healthcare at scale
“The acquisition of Practice Plus Group hospitals and surgical centres is an incredibly exciting step for Narayana Health,” he said, noting that both organisations share a vision of serving patients who are “in between” those who can afford high-end private care and those who only have access to basic services.
PPG Chief Executive Jim Easton welcomed the move, saying the UK operations would benefit from Narayana’s operational expertise and human-centric approach to care.
Analysts say the acquisition is significant on multiple fronts. It marks Narayana Health’s first major foray into the mature UK healthcare market, giving the Indian group exposure to the advanced private care sector and a steady revenue stream linked to NHS contracts.
The deal also strengthens Narayana’s standing among India’s healthcare providers, elevating its global footprint and positioning it for further international expansion.
From a strategic perspective, the acquisition provides Narayana with several tangible benefits.
The UK assets bring modern surgical centres specialising in high-volume, high-margin treatments; access to skilled clinical personnel and infrastructure; and a foothold in a regulated, high-income market that can complement its core operations in India and the Caribbean.
The acquisition also allows Narayana to leverage its digital and efficiency-driven care model in a new geography, building on its earlier international presence through its facility in the Cayman Islands.
However, execution will carry its share of challenges. Integrating cross-border operations, aligning clinical quality and cost structures, and navigating UK regulatory and healthcare market dynamics will demand strong governance and local management capability.
Market watchers suggest that ensuring seamless assimilation of UK practices into Narayana’s large and diverse ecosystem will be critical to realising the anticipated synergies.
For investors and stakeholders, the acquisition signals Narayana’s intent to transform from a domestic budget-care pioneer into a global multi-specialty healthcare player.
It underscores the growing maturity of India’s healthcare sector and its leading firms’ readiness to look outward for expansion.
As the deal moves toward closure, attention will turn to how Narayana positions its UK business within its broader strategy, how quickly operational and financial benefits accrue, and whether this marks the beginning of further international investment.
Also Read: Hindustan Unilever Faces Tax Demand of ₹1,986 Crore